Heart Stents stories:
Abbott, Medtronic: Heart Stents Top Rival In 3-Yr Study Data
Sep 21st, 2009 - Wall Street Journal
Stent heart devices from Abbott Laboratories (ABT) and Medtronic Inc. (MDT) outperformed an older device from Boston Scientific Corp. (BSX) in three-year data from two studies by better helping patients avoid serious events...
UPDATE: Medtronic To Pay Abbott $400 Million To Settle Stent Suits
Jul 27th, 2009 - CNNMoney
(Adds details on settlement and background on other Medtronic deals.) Of DOW JONES NEWSWIRES Medtronic Inc. (MDT) will pay rival Abbott Laboratories (ABT) $400 million...
Stent-Maker Xtent Nears End Of Road, Plans Liquidation
May 15th, 2009 - Wall Street Journal
Of DOW JONES NEWSWIRES Small heart-device developer Xtent Inc. (XTNT) is calling it quits after striking out in efforts to find a strategic or financial deal that would bring in needed resources to market and research its heart stents.
J&J’s Caruso Says Recession’s Effects on Company Won’t Worsen
Apr 14th, 2009 - Bloomberg
April 14 (Bloomberg) -- Johnson & Johnson doesn’t expectthe recession’s impact to worsen and is counting on new drugs tostanch losses to generic rivals before the year ends...
Boston Scientific Stents Less Effective Than Others in Studies
Mar 30th, 2009 - Bloomberg
March 30 (Bloomberg) -- Heart stents made by BostonScientific Corp., the world’s biggest seller of the artery-clearing devices, were less effective in studies than those fromAbbott Laboratories...



